Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | KHK | P50053 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | PGK1 | P00558 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20620010 | 0.85 | NPSR1 (0.49) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL11387117 | 0.85 | NPSR1 (0.49) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL2394013 | 0.85 | NPSR1 (0.57) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL30442040 | 0.85 | NPSR1 (0.57) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL20303775 | 0.85 | NPSR1 (0.57) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL2011637 | 0.84 | KDM4E (0.47) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL566209 | 0.84 | KHK (0.57) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL16370648 | 0.82 | CYP1A2 (0.54) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL6050497 | 0.82 | KHK (0.62) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 | |
| SCHEMBL16828824 | 0.82 | NPSR1 (0.54) | NPSR1CYP1A2CYP2C9CYP2C19ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | NPSR1 109/4885CYP1A2 2194/4885CYP2C9 1804/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.